150 related articles for article (PubMed ID: 19164263)
1. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
[No Abstract] [Full Text] [Related]
2. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
[No Abstract] [Full Text] [Related]
3. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
Opatrná S; Opatrný K; Racek J; Sefrna F
Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
[No Abstract] [Full Text] [Related]
4. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
Feriani M
Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
[No Abstract] [Full Text] [Related]
5. Understanding the variability in ultrafiltration obtained with icodextrin.
Lambie M; Stompor T; Davies S
Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
[No Abstract] [Full Text] [Related]
6. Ten years after MIDAS: icodextrin lights and shadows.
Amici G; Da Rin G; Agostini A; Velo S; Bocci C
Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
[No Abstract] [Full Text] [Related]
7. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
8. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
Gotloib L
Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
[No Abstract] [Full Text] [Related]
9. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
[TBL] [Abstract][Full Text] [Related]
10. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
[TBL] [Abstract][Full Text] [Related]
11. Alternative dialysis strategies with icodextrin.
Panzer SE; Teitelbaum I
Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709
[TBL] [Abstract][Full Text] [Related]
12. Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.
Orihuela O; de Jesús Ventura M; Ávila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Alcántara G; Lindholm B; García-López E; Villanueva C; Paniagua R
Perit Dial Int; 2014; 34(1):57-63. PubMed ID: 24525598
[TBL] [Abstract][Full Text] [Related]
13. Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD.
Bouchi R; Babazono T; Inoue A; Tanaka M; Tanaka N; Hase M; Ishii A; Iwamoto Y
Perit Dial Int; 2006; 26(5):604-7. PubMed ID: 16973520
[No Abstract] [Full Text] [Related]
14. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
[TBL] [Abstract][Full Text] [Related]
15. The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study.
Yehia M; Muyoma G; Topley N; Collins JF
Perit Dial Int; 2014; 34(7):810-3. PubMed ID: 25520490
[No Abstract] [Full Text] [Related]
16. Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?
Kuriyama S
Perit Dial Int; 2007 Jun; 27 Suppl 2():S190-5. PubMed ID: 17556303
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
18. [Is intermittent peritoneal dialysis with icodextrin a valid option in the long-term treatment of refractory congestive heart failure?].
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
G Ital Nefrol; 2009; 26 Suppl 46():44-9. PubMed ID: 19644817
[TBL] [Abstract][Full Text] [Related]
19. Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells.
Matsumoto M; Tamura M; Miyamoto T; Furuno Y; Kabashima N; Serino R; Shibata T; Kanegae K; Takeuchi M; Abe H; Okazaki M; Otsuji Y
Life Sci; 2012 Jun; 90(23-24):917-23. PubMed ID: 22564410
[TBL] [Abstract][Full Text] [Related]
20. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
Qi H; Xu C; Yan H; Ma J
Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
